Top Stories

Curated By Isabella Tang

By Isabella Tang 2026-01-02

BYD Achieves Record Electric Vehicle Sales in 2025

Chinese automaker BYD has reported unprecedented electric vehicle sales in 2025, solidifying its position as a leader in the EV market. The company's innovative strategies and expanding international presence are key factors in this remarkable growth.

By Isabella Tang 2026-01-02

2025 Heung Kong Entrepreneurs Forum Unites Innovators in Guangzhou

The 2025 Heung Kong Entrepreneurs Forum in Guangzhou brought together prominent business leaders and innovators from Hong Kong and Mainland China to discuss future opportunities. The event highlighted collaboration and investment prospects in the evolving economic landscape.

By Isabella Tang 2026-01-02

VS Media Holdings Limited Implements 1-for-20 Share Combination

VS Media Holdings Limited has announced a strategic 1-for-20 share combination aimed at enhancing shareholder value and improving market perception. This move reflects the company's commitment to optimizing its capital structure amidst evolving market conditions.

By Isabella Tang 2026-01-01

China's Biren Technology Raises $717 Million in Hong Kong IPO

Biren Technology, a prominent AI chip manufacturer in China, successfully raised $717 million through its initial public offering in Hong Kong. This significant funding highlights the growing demand for advanced semiconductor technologies in the global market.

By Isabella Tang 2026-01-01

A Mourning Hong Kong Rings in 2026 Without Fireworks

As Hong Kong ushers in the new year, the absence of fireworks marks a somber reflection of the city's ongoing struggles. The decision to forgo the traditional celebration underscores the deep sense of loss felt by many residents.

By Isabella Tang 2026-01-01

Insilico Medicine Successfully Lists on Hong Kong Stock Exchange

Insilico Medicine, backed by Qiming Venture Partners, has made a significant entry into the public market with its recent listing on the Hong Kong Stock Exchange. This milestone marks a pivotal moment for the biotechnology sector in Hong Kong, showcasing the region's growing prominence in global health innovation.